Position in LLY
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$55,349,919
+$6,555,144 QoQ
Shares Held
60,178
+32.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026THORNBURG INVESTMENT MANAGEMENT INC holds $1,242,934,030 across 7 Drug Manufacturers - General names. LLY ranks #5 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,858,651 | $563,783,150 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,728,673 | $448,522,075 | |
| 3 | ABBV |
AbbVie Inc.
|
502,832 | $109,360,931 | |
| 4 | PFE |
Pfizer Inc
|
2,242,186 | $62,960,582 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
60,178 | $55,349,919 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
38,400 | $2,328,960 | |
| 7 | NVS |
Novartis AG
|
4,114 | $628,413 |
All Filings in LLY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $55,349,919 | 60,178 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $48,794,775 | 45,404 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||